Trexquant Investment LP Atri Cure, Inc. Transaction History
Trexquant Investment LP
- $7.59 Billion
- Q3 2024
A detailed history of Trexquant Investment LP transactions in Atri Cure, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 77,331 shares of ATRC stock, worth $2.79 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
77,331
Previous 40,279
91.99%
Holding current value
$2.79 Million
Previous $917,000
136.42%
% of portfolio
0.03%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding ATRC
# of Institutions
212Shares Held
49.7MCall Options Held
12KPut Options Held
7.2K-
Vanguard Group Inc Valley Forge, PA4.66MShares$168 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$166 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.97MShares$143 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.83MShares$102 Million1.47% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.79MShares$101 Million0.5% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.67B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...